Elsaaran Hussein, AlQinai Shamlan, AlTarrah Dana, Abdulrasoul Mahdi, Al-Youha Sarah, Almazeedi Sulaiman, Al-Haddad Mohannad, Jamal Mohammad H, Al-Sabah Salman
COVID-19 Research Team, Jaber Al-Ahmad Hospital, Kuwait.
Faculty of Public Health, Kuwait University, Kuwait.
Ann Med Surg (Lond). 2021 Mar;63:102141. doi: 10.1016/j.amsu.2021.01.089. Epub 2021 Feb 5.
The development of barotrauma has been suggested to complicate the management of mechanically ventilated COVID-19 patients admitted to the intensive care unit (ICU). This study aims to identify potential risk factors associated with the development of barotrauma related complications in COVID-19 patients receiving mechanical ventilation.
A retrospective cohort study was carried out in a single COVID-19 designated center in Kuwait. Three hundred and forty-three confirmed COVID-19 patients transferred and/or admitted to our institution between February 26, 2020 and June 20, 2020 were included in the study. All patients were admitted into the ICU with the majority being mechanically ventilated (81.3%).
Fifty-four (15.4%) patients developed barotrauma, of which 49 (90.7%) presented with pneumothorax, and 14.8% and 3.7% due to pneumomediastinum and pneumopericardium respectively. Of those that developed barotrauma, 52 (96.3%) patients were in acute respiratory distress syndrome (ARDS). Biochemically, the white blood cells (p = 0.001), neutrophil percentage (p = 0.012), lymphocyte percentage (p = 0.014), neutrophil: lymphocyte ratio (NLR) (p=<0.001) and lactate dehydrogenase (LDH) (p = 0.002) were found to be significantly different in patients that developed barotrauma. Intubation due to low level of consciousness (p = 0.007), a high admission COVID-GRAM score (p = 0.042), and a positive-end expiratory pressure (PEEP) higher than the control group (p = 0.016) were identified as potential risk factors for the development of barotrauma.
Patients infected with COVID-19 have a significant risk of developing barotrauma when receiving invasive mechanical ventilation. This poses a substantial impact on the hospital course of the patients and clinical outcome, correlating to a higher mortality rate in this cohort of patients.
气压伤的发生被认为会使入住重症监护病房(ICU)的新型冠状病毒肺炎(COVID-19)机械通气患者的治疗变得复杂。本研究旨在确定接受机械通气的COVID-19患者发生气压伤相关并发症的潜在风险因素。
在科威特一个专门收治COVID-19患者的中心进行了一项回顾性队列研究。纳入了2020年2月26日至2020年6月20日期间转至和/或入住我院的343例确诊COVID-19患者。所有患者均入住ICU,大多数患者接受机械通气(81.3%)。
54例(15.4%)患者发生气压伤,其中49例(90.7%)表现为气胸,因纵隔气肿和心包积气导致气压伤的分别占14.8%和3.7%。在发生气压伤的患者中,52例(96.3%)患有急性呼吸窘迫综合征(ARDS)。生化检查发现,发生气压伤的患者白细胞(p = 0.001)、中性粒细胞百分比(p = 0.012)、淋巴细胞百分比(p = 0.014)、中性粒细胞与淋巴细胞比值(NLR)(p <0.001)和乳酸脱氢酶(LDH)(p = 0.002)有显著差异。因意识水平低而插管(p = 0.007)、COVID-GRAM评分高(p = 0.042)以及呼气末正压(PEEP)高于对照组(p = 0.016)被确定为发生气压伤的潜在风险因素。
感染COVID-19的患者在接受有创机械通气时发生气压伤的风险很高。这对患者的住院病程和临床结局有重大影响,与该队列患者较高的死亡率相关。